Wolfgang Prange

Title: Wolfgang Prange: Innovator in Transdermal Therapeutics

Introduction

Wolfgang Prange is a notable inventor based in Grafschaft, Germany. He has made significant contributions to the field of transdermal drug delivery systems, particularly focusing on the administration of memantine, a medication used to treat central nervous system disorders.

Latest Patents

Prange holds a patent for the transdermal administration of memantine. This invention relates to transdermal therapeutic systems (TTS) that utilize memantine or its physiologically compatible salts as the active ingredient. These systems are designed to effectively treat diseases of the central nervous system, showcasing Prange's innovative approach to medication delivery.

Career Highlights

Throughout his career, Wolfgang Prange has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with LTS Lohmann Therapie-Systeme AG and Grünenthal GmbH. His work in these organizations has contributed to advancements in therapeutic systems and drug delivery methods.

Collaborations

Prange has collaborated with esteemed colleagues, including René Eifler and Michael Horstmann. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective therapeutic solutions.

Conclusion

Wolfgang Prange's contributions to transdermal therapeutics highlight his role as an innovator in the pharmaceutical field. His patent for the transdermal administration of memantine represents a significant advancement in treating central nervous system diseases.